Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14.88x is 100% above its 4-year average of -5338.80x, near the high end of its 4-year range (-17826.00x–-5.81x).
As of the fiscal period ended Sunday, December 31, 2023.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -14.88x.
INTEREST COVERAGE RATIO
-14.88x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-9600.48x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+99.85%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-133.40%
vs the sector median at left
LeonaBio, Inc.
Market Cap
$22.28M
Interest Coverage Ratio
-14.88x
TTM Avg
N/A
3Y Avg
-9600.48x
5Y Avg
N/A
Market Cap
$22.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.79M
Interest Coverage Ratio
4.39x
TTM Avg
4.39x
3Y Avg
4.39x
5Y Avg
4.39x
Market Cap
$23.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.55M
Interest Coverage Ratio
-526.75x
TTM Avg
32.47x
3Y Avg
71.81x
5Y Avg
71.81x
Market Cap
$24.05M
Interest Coverage Ratio
-5.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.96M
Interest Coverage Ratio
-24.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.91M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.28M | -14.88x | N/A | -9600.48x | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.79M | 4.39x | 4.39x | 4.39x | 4.39x |
| Rein Therapeutics Inc. (RNTX)vs › | $23.21M | N/A | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.55M | -526.75x | 32.47x | 71.81x | 71.81x |
| Kyntra Bio, Inc. (KYNB)vs › | $24.05M | -5.24x | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.39M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.96M | -24.74x | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.91M | -17.20x | 55.75x | 55.75x | 55.75x |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A | N/A | N/A | N/A |
Interest Coverage
-14.9x
Debt/Equity
0.02
Current Ratio
7.01
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -14.88x |
| 2022-03-31 | -11693.50x |
| 2021-12-31 | -9389.00x |
| 2021-09-30 | -17826.00x |
| 2020-12-31 | -9079.00x |
| 2020-06-30 | -15.22x |
| 2020-03-31 | -5.81x |
| 2019-12-31 | -10.15x |
| 2019-09-30 | -15.66x |
